---
title: "New evidence shows tirzepatide and semaglutide strongly protect the heart"
date: 2025-11-22T04:10:04.000Z
category: Health
externalLink: "https://www.sciencedaily.com/releases/2025/11/251121090742.htm"
image: ""
excerpt: "A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabetes. While companies have claimed large differences favoring their own medications, researchers found only modest distinctions between the two blockbuster GLP-1 drugs.…"
---